573 filings
Page 5 of 29
8-K
ABVC
ABVC BioPharma Inc
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
ABVC
ABVC BioPharma Inc
16 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
424B4
ABVC
ABVC BioPharma Inc
15 Nov 22
Prospectus supplement with pricing info
2:36pm
424B3
ABVC
ABVC BioPharma Inc
15 Nov 22
Prospectus supplement
2:34pm
10-Q
2022 Q3
ABVC
ABVC BioPharma Inc
Quarterly report
14 Nov 22
4:43pm
8-K
ABVC
ABVC BioPharma Inc
21 Oct 22
Changes in Registrant's Certifying Accountant
4:30pm
8-K
ABVC
ABVC BioPharma Inc
13 Sep 22
ABVC Biopharma Announces Letter to Shareholders
10:47am
8-K
ABVC
ABVC BioPharma Inc
9 Sep 22
Departure of Directors or Certain Officers
4:30pm
424B4
ABVC
ABVC BioPharma Inc
25 Aug 22
Prospectus supplement with pricing info
4:31pm
424B3
ABVC
ABVC BioPharma Inc
25 Aug 22
Prospectus supplement
4:30pm
8-K
ABVC
ABVC BioPharma Inc
22 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
10-Q
2022 Q2
ABVC
ABVC BioPharma Inc
Quarterly report
15 Aug 22
5:08pm
8-K
ABVC
ABVC BioPharma Inc
14 Jul 22
Departure of Directors or Certain Officers
5:00pm
3
Jiang Shuling
12 Jul 22
ABVC BIOPHARMA / Shuling Jiang ownership change
5:01pm
SC 13D
Jiang Shuling
12 Jul 22
ABVC BIOPHARMA / Jiang Shuling ownership change
5:00pm
424B4
ABVC
ABVC BioPharma Inc
11 Jul 22
Prospectus supplement with pricing info
4:01pm
424B3
ABVC
ABVC BioPharma Inc
11 Jul 22
Prospectus supplement
4:00pm
EFFECT
ABVC
ABVC BioPharma Inc
24 Jun 22
Notice of effectiveness
12:15am
POS AM
ABVC
ABVC BioPharma Inc
22 Jun 22
Prospectus update (post-effective amendment)
7:50pm
8-K
ABVC
ABVC BioPharma Inc
21 Jun 22
ABVC BioPharma Expands Co-Development Partnership with Rgene Corporation
2:07pm